Sign in to follow
Search Results

0 results for 'BristolMyers Squibb'

You can use to get even better search results
February 15, 2019 | Law.com

Whole Foods Asks DC Circuit to Apply 'Bristol-Myers' to Limit Class Action Jurisdiction

The U.S. Court of Appeals for the D.C. Circuit could be the first appeals court to rule on whether "Bristol-Myers Squibb v. Superior Court of California" applied to class actions.
6 minute read
April 11, 2017 |

Bristol-Myers Squibb, Pfizer Unload Slew of Eliquis Infringement Cases

Bristol-Myers Squibb Co. and Pfizer Inc. on Monday filed a slew of patent infringement suits in Delaware to protect their patents for the successful drug Eliquis and halt the development of generic versions of the profitable blood thinner.
6 minute read
December 08, 2016 |

Bristol-Myers Squibb Agrees to $19.5M Settlement Over Abilify Marketing

Drugmaker Bristol-Myers Squibb has agreed to settle claims that it improperly marketed its antipsychotic drug Abilify by paying out $19.5 million to 42 states.
6 minute read
July 28, 2016 | Insurance Coverage Law Center

Whistleblower Lawsuit Leads to $30 Million Settlement with Bristol-Myers Squibb

The California Insurance Department has reached a $30 million settlement with Bristol-Myers Squibb over allegations of drug marketing fraud and physician…
3 minute read
November 17, 2015 |

Confer v. Bristol-Myers Squibb Co.

Defendants Granted Dismissal of Injury Suit Based on Forum Non Conveniens Grounds
1 minute read
October 05, 2015 |

Bristol-Myers Squibb Settles China Bribery Case for $14.7 Million

The New York-based company agreed to settle civil charges that its joint venture in China bribed health care providers at state-controlled hospitals in order to promote drug sales.
3 minute read
October 02, 2014 | Insurance Coverage Law Center

Bristol-Myers Squibb to Transfer $1.4 Billion in U.S. Pension Obligations to Prudential

Bristol-Myers Squibb Company will settle $1.4 billion in pension obligations through the purchase of a group annuity contract from The Prudential…
1 minute read
April 18, 2002 |

After Cipro Battle, Patent-Busting Is Still Live Issue

Last fall, politicians and the media alike discussed the possibility of "busting" Bayer's patents on Cipro so that the government and generic drug companies could satisfy an alleged shortage of the anthrax-fighting drug. Although Bayer and the U.S. government eventually reached a settlement, the topic of patent-busting could arise again, so the potential problems of such an action merit discussion.
11 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now

    • Practical Guidance Journal: Protecting Work Product in a Generative AI World

      Brought to you by LexisNexis®

      Download Now